RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of EPIX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

ESSA Pharma Inc. stock price down 3.28% on Wednesday
(Updated on Mar 27, 2024)

Sell candidate since Mar 20, 2024 Loss -6.96% PDF

The ESSA Pharma Inc. stock price fell by -3.28% on the last day (Wednesday, 27th Mar 2024) from $8.85 to $8.56. During the last trading day the stock fluctuated 8.12% from a day low at $8.50 to a day high of $9.19. The price has fallen in 6 of the last 10 days and is down by -5.31% for this period. Volume has increased on the last day by 109 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 139 thousand shares were bought and sold for approximately $1.19 million.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $7.86 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 18.41% during the next 3 months and, with a 90% probability hold a price between $9.31 and $13.81 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

EPIX Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The ESSA Pharma Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $9.02 and $9.12. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, February 07, 2024, and so far it has fallen -19.62%. Further fall is indicated until a new bottom pivot has been found. ESSA Pharma Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for ESSA Pharma Inc. stock

ESSA Pharma Inc. finds support from accumulated volume at $8.51 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $0.690 (8.12%) between high and low. For the last week, the stock has had daily average volatility of 5.67%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (EPIX) For The Upcoming Trading Day Of Thursday 28th

For the upcoming trading day on Thursday, 28th we expect ESSA Pharma Inc. to open at $8.75, and during the day (based on 14 day Average True Range), to move between $7.95 and $9.17, which gives a possible trading interval of +/-$0.611 (+/-7.14%) up or down from last closing price. If ESSA Pharma Inc. takes out the full calculated possible swing range there will be an estimated 14.28% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $8.51 (0.58%) than the resistance at $10.43 (21.85%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is ESSA Pharma Inc. stock A Buy?

The ESSA Pharma Inc. stock holds several negative signals and despite the positive trend, we believe ESSA Pharma Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -2.343 Sell Candidate Unchanged

Predicted Opening Price for ESSA Pharma Inc. of Thursday, March 28, 2024

Fair opening price March 28, 2024 Current price
$8.75 ( 2.22%) $8.56

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for EPIX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 9.44 10.28 %
R2 9.18 7.20 %
R1 9.01 5.30 %
Current price: 8.56
Support S1 8.49 -0.86 %
S2 8.32 -2.76 %
S3 8.06 -5.84 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 10.65 24.42 %
R2 10.45 22.08 %
R1 10.43 21.85 %
Current price 8.56
Support S1 8.51 -0.584%
S2 8.49 -0.82%
S3 6.80 -20.56%

FAQ

What is the symbol for ESSA Pharma Inc. Stock and on which exchange is it traded?
The symbol for ESSA Pharma Inc. is EPIX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell ESSA Pharma Inc. Stock?
The ESSA Pharma Inc. stock holds several negative signals and despite the positive trend, we believe ESSA Pharma Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy ESSA Pharma Inc. Stock?
ESSA Pharma Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy ESSA Pharma Inc. Stock.

What's the current price of ESSA Pharma Inc. Stock?
As of the end of day on the 2024-03-27, the price of an ESSA Pharma Inc. (EPIX) share was $8.56.

What is the 52-week high and low for ESSA Pharma Inc. Stock?
The 52-week high for ESSA Pharma Inc. Stock is $11.67 and the 52-week low is $2.56.

What is the market capitalization of ESSA Pharma Inc. Stock?
As of the 2024-03-27, the market capitalization of ESSA Pharma Inc. is 378.679M.

When is the next earnings date for ESSA Pharma Inc.?
The upcoming earnings date for ESSA Pharma Inc. is May 14, 2024.
Click to get the best stock tips daily for free!

About ESSA Pharma Inc.

ESSA Pharma. ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreements with Caris Life Sciences, Inc.; Bayer Consumer Care AG; Janssen Research & Development, LLC; and A... EPIX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT